Atezolizumab Plus Bevacizumab and Chemotherapy in First-Line Metastatic Nonsquamous NSCLC
NCT05261438 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 70
Last updated 2022-03-02
Summary
This study aimed to explore the efficacy of Atezolizumab Plus Bevacizumab and Chemotherapy in First-Line Metastatic Non-squamous NSCLC.
Conditions
Sponsors & Collaborators
-
Hunan Province Tumor Hospital
lead OTHER
Principal Investigators
-
Yongchang Zhang, MD · Hunan Cancer Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-09-01
- Primary Completion
- 2021-05-01
- Completion
- 2021-09-15
Countries
- China
Study Locations
More Related Trials
-
Exploration of Immunodynamic Monitoring in the Population Evaluation of Neoadjuvant Chemotherapy Immunotherapy in Patients With Solid Tumors of the Chest.
NCT05044728 ·Status: UNKNOWN ·Phase: PHASE2
-
Evaluating the Safety and Efficacy of Pembrolizumab Combined With MWA for Advanced NSCLC
NCT03769129 ·Status: RECRUITING ·Phase: NA
-
Microwave Plus Chemotherapy Versus Chemotherapy for Advanced NSCLC
NCT02455843 ·Status: UNKNOWN ·Phase: PHASE3
-
Tislelizumab Plus Chemotherapy as First-Line Treatment for Advanced Squamous NSCLC With Brain Metastases
NCT05207904 ·Status: UNKNOWN ·Phase: PHASE2
-
Neoadjuvant Immune Checkpoint Inhibitor Combined With Chemotherapy in Non-small Cell Lung Cancer
NCT04945200 ·Status: UNKNOWN
-
Chemotherapy Combined With Immunotherapy in HER 2 Insertion or Amplification Advanced NSCLC
NCT04324125 ·Status: RECRUITING
-
The Therapeutic Effect of Immunotherapy in Patients With Advanced Lung Squamous Carcinoma
NCT06647836 ·Status: ENROLLING_BY_INVITATION
-
Efficacy and Safety of Conventional and Low-dose Platinum Gemcitabine Combined With Cindilimab With Delayed Administration in First-line Treatment of Advanced Squamous Non-small Cell Lung Cancer
NCT05312840 ·Status: UNKNOWN ·Phase: PHASE4
-
Real-world First-line Sugemalimab-Chemotherapy in Advanced NSCLC
NCT07247227 ·Status: RECRUITING ·Phase: NA
-
A Real-world Study of the Efficacy and Safety of PD-1 Inhibitors Combined With Chemoradiotherapy in Lung Metastatic Nasopharyngeal Carcinoma
NCT07062484 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Targeted or Chemotherapy Combined With Immunotherapy Versus Chemotherapy for PD-1 Inhibitor Refractory R/M NPC
NCT05549466 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy and Safety of Immunotherapy in Non-small Cell Lung Cancer With Uncommon Histological Type
NCT05023837 ·Status: COMPLETED
-
Study of Chemoradiotherapy Combined With Cetuximab in Nasopharyngeal Carcinoma
NCT01271439 ·Status: COMPLETED ·Phase: PHASE2
-
Bronchoscopic Microwave Intervention Treatment in Advanced Central NSCLC
NCT04360655 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of Sintilimab Plus Bevacizumab in Metastatic Nasopharyngeal Carcinoma After Failure of Platinum-based Chemotherapy: An Open-label Phase II Study
NCT04872582 ·Status: UNKNOWN ·Phase: PHASE2
-
Bronchoscopic Cryoablation Combined With Chemo-Immunotherapy in NSCLC With Central Airway Obstruction
NCT06604351 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Combining RT With Immunotherapy and Chemotherapy in Metastatic Nasopharyngeal Carcinoma
NCT05385926 ·Status: RECRUITING ·Phase: PHASE2
-
Real-world Association Between Concomitant Beta-blocker Exposure and Anti-PD-1/PD-L1 Treatment Outcomes in Advanced Non-Small Cell Lung Cancer
NCT05387512 ·Status: COMPLETED
-
Study of Pembrolizumab Combined with Chemotherapy in the First Line Therapy for R/M HNSCC in China
NCT04857164 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of IBI351 in Combination With Chemotherapy in Advanced Non-squamous Non-small Cell Lung Cancer Subjects With KRAS G12C Mutation
NCT05504278 ·Status: RECRUITING ·Phase: PHASE1
-
A Trial of Sugemalimab and Chemotherapy in Unresectable Stage III NSCLC
NCT05940532 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of Use of Platinum Based Doublet Chemotherapy Plus Antiangiogenesis and Immune Checkpoint Inhibitors in Patients With Advanced Non-squamous Non-small Cell Lung Cancer
NCT04137588 ·Status: UNKNOWN
-
Induction Chemotherapy and Toripalimab Followed by Chemoradiotherapy for Large-volume Local Advanced NSCLC
NCT05888402 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
The Real World Study of Neoadjuvant Immunotherapy in Early Stage NSCLC in China
NCT04286841 ·Status: RECRUITING
-
Maintenance Gemcitabine in the Chinese Advanced Lung Cancer
NCT01336192 ·Status: UNKNOWN ·Phase: PHASE4